Monopar Therapeutics Q3 EPS $(0.72) Beats $(0.80) Estimate
Benzinga Newsdesk 8 hours ago
NewsEarningsEarnings Beats
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.80) by 10 percent. This is a 50 percent decrease over losses of $(0.48) per share from
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(0.80) by 10 percent. This is a 50 percent decrease over losses of $(0.48) per share from the same period last year.